Galectin therapeutics inc

Major-Pharmaceuticals

GALT


4960 Peachtree Industrial Boulevard
Norcross , GA 30071

Executive/
Director

Price

  • Last Close
  • $ 1.9
    $ -0.83 -30.4 %
    Dec 9, 2024
  • 52-Week High/Low
  • $4.18 - $1.6
  • YTD
  • 14.5%

  • Trading Volume
  • 73,778
  • Market Cap Full
  • $ 117.5M
  • Shares Outstanding
  • 61.8M
    Nov 8, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -3.5% -12.8% 134.7% 41.9% 49% -5% -5.8% -23.3% 85.8% 44%
Q2 -18.5% 2.8% 7% 54.4% -19.4% 4% 51.7% -18.6% -31.4% 2.9%
Q3 -14.3% -23.1% -13% -8.2% -12.1% 8% 24.4% 24.4% 33.3% -
Q4 -29.9% -13.3% 36.9% -40.2% -21.3% -16.1% -47.2% -30.7% -13.5% -
J F M A M J J A S O N D
2024 1.8% 15.7% 22.3% 5% - - - - - - - -
2023 2.7% 78.5% 1.5% -16.2% -10.8% -8.3% 4.2% 16.7% 9.7% 6.3% -4.4% -14.9%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    -57%-53%-40%241%3%-16%-22%-6%-46%47%14%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.22 0.24 0.15 -0.12 -0.2 -0.06 -0.11 -0.17 -0.19
Q2 0.21 0.20 0.14 -0.11 -0.06 -0.11 -0.15 -0.16 -0.15
Q3 0.26 0.19 0.13 -0.07 -0.05 -0.1 -0.14 -0.14 -0.24
Q4 0.19 0.13 0.07 -0.08 -0.08 -0.14 -0.12 -0.18 -
A 0.9 0.8 0.5 -0.4 -0.4 -0.4 -0.5 -0.7 -0.58

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 45.6 57 57.2 59.4 59.4
Jun 37.7 45.6 57 58.1 59.4 59.6
Sep 40.9 56.6 57 59.3 59.4 59.6
Dec 41.1 56.9 57.1 59.3 59.4 61.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Interest Coverage -38 -30 - - -
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Equity multiplier - - - - -